Polycythemia Vera (PV)-3
Lab features:
Pancytosis
of bone marrow and peripheral blood
Myelosuppressive
therapy using:
32P
Spent
phase:
Acute
leukemia in 15% of cases
Alkylating
drugs
hydroxyurea
Therapy:
Prognosis:
splenomegaly
Bone
marrow hyperplasia
Peripheral
blood cytopenias
Extramedullary
hematopoiesis
Risk
increases if on myelosuppressive therapy
Click to review comparison of erythrocytosis
